Iqvia and DCRI have formed a strategic collaboration to enhance the design and execution of obesity and cardiometabolic clinical trials, combining global operational capabilities with academic research expertise.
Clinical Research | 12/02/2026 | By News Bureau
FIU Researchers Advance Functional Precision Medicine for Hard to Treat Cancers
FIU researchers are advancing functional precision medicine for hard-to-treat cancers, with new funding accelerating drug sensitivity testing to identify personalized, effective therapies beyond conventional genetic approaches.
Clinical Research | 22/01/2026 | By News Bureau
Worldwide Clinical Trials to Acquire Catalyst Clinical Research
Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a move aimed at expanding its functional service provider capabilities, strengthening its global site network, boosting oncology expertise, and accelerating technology integration to enhance efficiency and transparency for customers.
Clinical Research | 21/01/2026 | By News Bureau | 206
FDA Publishes Guidance on Modern Statistical Methods for Clinical Research
The FDA guidance provides a framework for applying Bayesian analyses in clinical research, enabling data-driven assessments of safety and efficacy using both current and prior evidence.
Clinical Research | 14/01/2026 | By News Bureau
WHO Report Highlights Major Equity Gaps in Human Genomics Research
A new WHO analysis highlights major equity gaps in human genomics research, despite rapid growth in the field, with over 6,500 clinical studies registered globally, largely focused on cancer and rare diseases.
Clinical Research | 24/12/2025 | By News Bureau
PharmAla Biotech Australia Ties Up with UK CDMO to Manufacture ALA-002
PharmAla Biotech Australia has contracted a UK-based CDMO to manufacture the drug substance for ALA-002, its patented non-racemic MDMA formulation, ahead of planned phase 2a/2b clinical trials for social anxiety disorder expected to begin in 2026.
Clinical Research | 16/12/2025 | By News Bureau
Terns Prices Upsized USD 650 Million Public Offering
Terns plans to use the proceeds to advance research and clinical development of its pipeline, including TERN-701, support early commercial launch preparations, and fund working capital and general corporate needs.
Clinical Research | 10/12/2025 | By Akanki
UK Halves Clinical Trial Approval Times Through Major Digital Reforms
Backed by major reforms and new digital platforms at the Medicines and Healthcare products Regulatory Agency (MHRA), the UK has reduced the average clinical trial approval time by more than half — from 91 days to just 41 days.
Clinical Research | 08/10/2025 | By Dineshwori | 229
Julius Clinical Strengthens CNS and Cardiometabolic Expertise, Adds Operations in Spain and Germany
Julius Clinical has reported strong Q2 2025 growth in CNS and Cardiometabolic bookings, driven by its merger with Peachtree BioResearch Solutions and expanded operations in Spain and Germany.
Clinical Research | 04/09/2025 | By Mrinmoy Dey | 157
Eximia Research Acquires Integrated Clinical Trial Services
With this expansion into Iowa, this partnership marks another significant milestone in Eximia's mission to broaden access to cutting-edge clinical trials and innovative healthcare solutions across the nation.
Clinical Research | 17/10/2024 | By Aishwarya | 553
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy